Centogene N.V.

Symbol: CNTG

NASDAQ

0.71

USD

Market price today

  • -0.3156

    P/E Ratio

  • 0.0918

    PEG Ratio

  • 19.78M

    MRK Cap

  • 0.00%

    DIV Yield

Centogene N.V. (CNTG) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.39%

Operating Profit Margin

-0.76%

Net Profit Margin

-0.86%

Return on Assets

0.00%

Return on Equity

5.60%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Diagnostics & Research
CEO:Ms. Kim Stratton
Full-time employees:444
City:Rostock
Address:Am Strande 7
IPO:2019-11-07
CIK:0001757097

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

General Outlook

When we look at how much money they make before expenses, they keep 0.390% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.757%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.857%. This tells us they're good at keeping money after all costs.

Return on Investments

Centogene N.V.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 5.605%.

Stock Prices

Centogene N.V.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.45, while its low point bottomed out at $0.4303. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Centogene N.V.'s stock market.

Profitability Ratios

CNTG profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -85.74% underscores its earnings before tax deductions. The effective tax rate stands at -0.15%, revealing its tax efficiency. The net income per EBT, 99.93%, and the EBT per EBIT, 113.24%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -75.72%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-85.74%
Effective Tax Rate-0.15%
Net Income per EBT99.93%
EBT per EBIT113.24%
EBIT per Revenue-75.72%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.73, and free cash flow per share, -0.72, depict cash generation on a per-share basis. Lastly, the operating cash flow sales ratio, -0.54, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.73
Free Cash Flow per Share-0.72
Operating Cash Flow Sales Ratio-0.54
Free Cash Flow to Operating Cash Flow Ratio0.99
Capital Expenditure Coverage Ratio-94.63
Dividend Paid and Capex Coverage Ratio-94.63

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.77, provides a glimpse into top-line earnings distributed across each share. Net income per share, -1.44, reflects the portion of profit attributed to each share.

cards.indicatorcards.value
Revenue Per Share1.77
Net Income Per Share-1.44
Book Value Per Share0.28
Shareholders Equity Per Share0.28
Interest Debt Per Share2.38
Capex Per Share-0.08

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -75.00%, indicates top-line expansion, while the gross profit growth, -29.82%, reveals profitability trends. EBIT growth, 18.52%, and operating income growth, 18.52%, offer insights into operational profitability progression. The net income growth, 17.39%, showcases bottom-line expansion, and the EPS growth, 31.10%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-75.00%
Gross Profit Growth-29.82%
EBIT Growth18.52%
Operating Income Growth18.52%
Net Income Growth17.39%
EPS Growth31.10%
EPS Diluted Growth31.10%
Weighted Average Shares Growth19.49%
Weighted Average Shares Diluted Growth19.49%
Operating Cash Flow Growth-21.85%
Free Cash Flow Growth-4.16%
10-Year Revenue Growth per Share27.10%
5-Year Revenue Growth per Share10.98%
3-Year Revenue Growth per Share-40.44%
10-Year Operating CF Growth per Share-1511.64%
5-Year Operating CF Growth per Share-352.53%
3-Year Operating CF Growth per Share-108.51%
10-Year Net Income Growth per Share-435.00%
5-Year Net Income Growth per Share-423.57%
3-Year Net Income Growth per Share-13.58%
10-Year Shareholders Equity Growth per Share82.88%
5-Year Shareholders Equity Growth per Share-67.20%
3-Year Shareholders Equity Growth per Share-92.42%
Receivables Growth-32.00%
Inventory Growth-52.99%
Asset Growth2.34%
Book Value per Share Growth-77.29%
Debt Growth163.55%
R&D Expense Growth-9.37%
SGA Expenses Growth-28.40%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 51,485,164.972, captures the company's total value, considering both debt and equity. Income quality, 0.84, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.62, gauges operational efficiency, while the research and development to revenue, 36.84%, highlights investment in innovation. The ratio of intangibles to total assets, 7.97%, indicates the value of non-physical assets, and capex to operating cash flow, 7.91%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value51,485,164.972
Income Quality0.84
Sales General and Administrative to Revenue0.62
Research and Development to Revenue36.84%
Intangibles to Total Assets7.97%
Capex to Operating Cash Flow7.91%
Capex to Revenue-4.41%
Capex to Depreciation-20.18%
Graham Number3.00
Return on Tangible Assets-45.31%
Graham Net Net-1.49
Working Capital35,167,000
Tangible Asset Value11,000
Net Current Asset Value-25,569,000
Invested Capital8
Average Receivables20,442,500
Average Payables8,784,500
Average Inventory2,844,000
Days Sales Outstanding127
Days Payables Outstanding83
Days of Inventory On Hand24
ROIC-54.22%
ROE-5.22%

Valuation Ratios

The price to sales ratio, 0.27, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.52, and price to operating cash flows, -0.51, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price to Sales Ratio0.27
Price Cash Flow Ratio-0.51
Price Earnings to Growth Ratio0.09
Enterprise Value Multiple-0.44
Price to Operating Cash Flow Ratio-0.51
Price to Free Cash Flows Ratio-0.52
Price to Tangible Book Ratio3.15
Enterprise Value to Sales1.08
Enterprise Value Over EBITDA-1.98
EV to Operating Cash Flow-1.94
Earnings Yield-165.60%
Free Cash Flow Yield-122.30%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Centogene N.V. (CNTG) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.316 in 2024.

What is the ticker symbol of Centogene N.V. stock?

The ticker symbol of Centogene N.V. stock is CNTG.

What is company IPO date?

IPO date of Centogene N.V. is 2019-11-07.

What is company current share price?

Current share price is 0.710 USD.

What is stock market cap today?

The market cap of stock today is 19784718.000.

What is PEG ratio in 2024?

The current 0.092 is 0.092 in 2024.

What is the number of employees in 2024?

In 2024 the company has 444.